CD33 and Alzheimer disease: Another phagocytic receptor, CD33, acts as the upstream regulator of TREM2, and studies have confirmed that the crosstalk between CD33 and TREM2 promotes the pathogenesis of AD via regulating the IL-1β/IL-1RN singling pathway (53).